NLRP3 and fibrosis: Previous studies have revealed the protective effects of blocking the inflammasomes NLRP3 on cardiac dysfunction, such as reducing cardiac fibrosis and preserving contractile function in mice and in patients with cardiac dysfunction [8,9,35,36].